What Are the Challenges in Using the ECS for Cancer Treatment?
Although there is promising preclinical evidence, several challenges hinder the clinical application of ECS-targeted therapies in cancer. These include variability in response among different cancer types, the psychoactive effects of certain cannabinoids, and the lack of standardized dosing regimens. Moreover, there is a need for comprehensive clinical trials to establish safety and efficacy.
